Neovascular glaucoma （NVG） is a blinding, intractable disease, which is difficult to manage. It is referred to as an ＂end-stage＂ ocular disease. Conventional treatments for extremely uncontrolled NVG cases include...Neovascular glaucoma （NVG） is a blinding, intractable disease, which is difficult to manage. It is referred to as an ＂end-stage＂ ocular disease. Conventional treatments for extremely uncontrolled NVG cases include retinal cryotherapy or enucleation. Major advancements in the diagnosis and the treatment of NVG, such as glaucoma drainage implant surgery and anti-vascular endothelial growth factor （anti-VEGF） treatment, have led to a new era in the management of this condition. However, many challenges still remain to be overcome.展开更多
基金This research was supported by grants from the National Natural Science Foundation of China （No. 81170849 and No. 81371008）. Conflicts of interest： none.
文摘Neovascular glaucoma （NVG） is a blinding, intractable disease, which is difficult to manage. It is referred to as an ＂end-stage＂ ocular disease. Conventional treatments for extremely uncontrolled NVG cases include retinal cryotherapy or enucleation. Major advancements in the diagnosis and the treatment of NVG, such as glaucoma drainage implant surgery and anti-vascular endothelial growth factor （anti-VEGF） treatment, have led to a new era in the management of this condition. However, many challenges still remain to be overcome.
